β‘ Pyruvate kinase (PK) deficiency results in reduced ATP production within red blood cells (RBCs).
π§ͺ This leads to high levels of 2,3-DPG, which disrupts the pentose phosphate pathway, ultimately causing premature haemolysis of RBCs.
About
- 𧬠Pyruvate kinase deficiency is an inherited autosomal recessive condition affecting RBCs.
- β‘ Deficient ATP production shortens RBC lifespan β chronic haemolytic anaemia.
- π©Έ Classified as a congenital non-spherocytic haemolytic anaemia.
Epidemiology
- π¨βπ©βπ§ Autosomal recessive inheritance pattern.
- π Patients are homozygous or compound heterozygotes for PKLR gene mutations.
Aetiology
- π§ͺ Pyruvate kinase is essential in glycolysis, converting phosphoenolpyruvate (PEP) β pyruvate and generating ATP.
- β Mutations in the PKLR gene reduce enzyme activity β inadequate ATP production in RBCs.
- π Without ATP, RBCs lose flexibility β fragile cells removed by the spleen (extravascular haemolysis).
- π High 2,3-DPG shifts Oβ dissociation curve right β easier oxygen release but worsens RBC instability.
Clinical Features
- π Variable: from severe neonatal haemolysis to mild anaemia detected in adulthood.
- π‘ Pallor, jaundice, fatigue, splenomegaly, and pigment gallstones.
- πΆ Neonates: severe jaundice, anaemia, sometimes requiring exchange transfusions.
- π¦ Aplastic crises may occur with Parvovirus B19 β sudden severe anaemia.
Investigations
- π¬ Blood film: βprickle cellsβ (spiculated red cells).
- π Low haemoglobin (anaemia, severity variable).
- π Reticulocytosis, raised LDH, raised bilirubin.
- β¬οΈ Low haptoglobin (consumed in haemolysis).
- π§ͺ DAT/Coombs test negative (non-immune haemolysis).
- β
Confirmed by measuring reduced RBC pyruvate kinase activity.
Complications
- π Pigment gallstones (from chronic haemolysis).
- π¦ Aplastic crises with viral infections (e.g. Parvovirus B19).
- βοΈ Iron overload from repeated transfusions.
Management
- π©Ί Depends on severity:
- π Supportive transfusions for severe anaemia (esp. during crises).
- π± Daily folic acid (5 mg) to aid erythropoiesis.
- βοΈ Splenectomy considered in severe haemolysis/high transfusion needs (reduces RBC destruction).
- π¦ During aplastic crises β intensive transfusion support + monitoring.
- π§² Iron chelation if frequent transfusions cause overload.
Cases β Pyruvate Kinase Deficiency
- Case 1 β Neonatal jaundice πΆ: A 3-day-old boy develops severe jaundice and anaemia. Family history: cousin required neonatal exchange transfusion. Bloods: unconjugated hyperbilirubinaemia, reticulocytosis, negative Coombs test. Peripheral smear: echinocytes (burr cells). Diagnosis: congenital PK deficiency causing haemolytic anaemia. Managed with phototherapy, transfusion support, and monitoring for kernicterus.
- Case 2 β Chronic haemolysis in childhood π§: A 7-year-old girl presents with pallor, fatigue, and intermittent scleral icterus. Splenomegaly noted on exam. FBC: Hb 8.2 g/dL, reticulocytes high. Iron studies: raised ferritin (from chronic transfusions). Diagnosis: PK deficiency with chronic non-spherocytic haemolytic anaemia. Managed with folate supplementation, occasional transfusions, and splenectomy consideration.
- Case 3 β Adult presentation with gallstones π: A 28-year-old man with lifelong mild anaemia presents with right upper quadrant pain. Ultrasound: gallstones. Bloods: Hb 10.5 g/dL, raised indirect bilirubin. Peripheral smear: echinocytes. Diagnosis: PK deficiency with pigment gallstones secondary to chronic haemolysis. Managed with cholecystectomy and supportive haematology follow-up.
Teaching Point π©Ί: Pyruvate kinase deficiency is a rare autosomal recessive cause of chronic non-spherocytic haemolytic anaemia. Red cells cannot generate enough ATP β membrane instability β haemolysis. Features: neonatal jaundice, chronic anaemia, splenomegaly, gallstones, iron overload. Management: folate, transfusions, splenectomy, iron chelation.